Design: Cluster randomized trial
• Unit of randomization: Public health center
• Population: Females and males, 15-24 years Inclusion: living
with HIV, care in study clinic
• Setting: 28 health centers in rural western Kenya and
southwestern Uganda
• Primary endpoint: Proportion with viral suppression (HIV
RNA < 400c/mL) after 2 years of individual follow-up.
• Study power: 20% difference in viral suppression 
